- Bicuspid aortic valve disease (BAVD), a congenital cardiovascular condition, is becoming an increasingly critical area of focus in cardiology due to its progressive nature and association with serious complications such as aortic stenosis, regurgitation, and aneurysm, necessitating timely diagnosis and intervention
- The rising prevalence of congenital heart defects, growing adoption of minimally invasive valve replacement procedures, and advancements in diagnostic imaging technologies are major factors driving the market demand for effective and tailored BAVD treatments
- North America dominated the bicuspid aortic valve disease market with the largest revenue share of 39% in 2024, attributed to robust cardiac care infrastructure, early uptake of transcatheter interventions, and active research efforts led by key players in the U.S. and Canada
- Asia-Pacific is expected to be the fastest growing region in the bicuspid aortic valve disease market during the forecast period due to expanding healthcare access, improving diagnostic capabilities, and rising awareness of congenital heart disorders
- Aortic Valve Surgery segment dominated the bicuspid aortic valve disease market with a market share of 39.1% in 2024, supported by its established clinical success in treating severe cases and its widespread availability across leading cardiac centers globally
